Syncom Formulations (India) Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Syncom Formulations (India) Limited generated cash of -$59,583,000, which is less than the previous year. Cash used in financing activities reached the amount of -$145,576,000 last year. Net change in cash is therefore $625,037,000.
Cash Flow
| 2016 | 241.74M | -228.48M | -24.05M |
|---|---|---|---|
| 2018 | -16.00M | -21.62M | -20.48M |
| 2020 | -5.05M | 13.52M | 113.48K |
| 2021 | -19.93M | -754.62M | 719.60M |
| 2023 | 105.29M | -449.52M | 350.01M |
| 2024 | -59.58M | 830.19M | -145.57M |
SYNCOMF.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 8.79M | 3.01M | 82.07M | 73.49M | 65.71M | 67.73M |
Operating activities | ||||||
Net income | 253.14M | 265.59M | 406.73M | 173.40M | 121.16M | 162.02M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 47.22M | 45.39M | 40.34M | 40.61M | 37.29M | 29.98M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -277.91M | -79.57M | -314.8M | -20.13M | 82.94M | -148.38M |
Inventories | 1.18M | -16.94M | -64.82M | -23.48M | -10.27M | -45.29M |
Accounts payable | 36.97M | 66.55M | 90.02M | -8.67M | -99.56M | 270.23M |
Cash generated by operating activities | -59.58M | 105.29M | -19.93M | -5.05M | -16.00M | 241.74M |
Investing activities | ||||||
Purchases Of Investments | 0 | -189.78M | -96.93M | -69.29M | -17.27M | -169.89M |
Investments In Property Plant And Equipment | -81.36M | -206.34M | -27.25M | -17.48M | -66.32M | -79.90M |
Acquisitions Net | 15.55M | 0 | 0 | 0 | 52.77K | 991K |
Cash generated by investing activities | 830.19M | -449.52M | -754.62M | 13.52M | -21.62M | -228.48M |
Financing activities | ||||||
Common Stock Issued | 0 | 145.78M | 121.06M | 0 | 0 | 0 |
Payments for dividends | 0 | -28.2M | 0 | 0 | -18.79M | -15.61M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -106.94M | 253.90M | -599.42M | -65.26M | 0 | -4.55M |
Cash used in financing activities | -145.57M | 350.01M | 719.60M | 113.48K | -20.48M | -24.05M |
Net Change In Cash | 625.03M | 5.78M | -27.30M | 8.58M | -58.11M | -10.79M |
Cash at end of period | 633.83M | 8.79M | 54.76M | 82.07M | 7.60M | 56.94M |
| Data source | Data source | Data source | Data source | Data source | Data source |